Business Context and Reporting Period
This Form 6-K filing by Farmmi, Inc. covers the month of March 2025, with the report dated March 6, 2025. The filing discloses two material corporate transactions: an equity acquisition in the forestry sector and a debt-to-equity exchange agreement.
Key Financial Metrics and Transactions
Equity Acquisition
- Target: 45% equity interest in EWAYFOREST GROUP LIMITED (Target), which controls Lishui Senbo Forestry Co., Ltd.
- Appraised Value: The Target was appraised at approximately RMB 1.6 billion (approx. $220.2 million) as of December 31, 2024.
- Purchase Price: Total consideration of RMB 723,324,150 (approx. $99,085,500).
- Payment Structure:
- $35 million in cash.
- $35 million in accounts receivable (due by March 31, 2025).
- $29,085,500 remaining balance (due by September 2025).
Debt-to-Equity Exchange
- Original Debt: Unsecured promissory note of $5,355,000 issued to Atlas Sciences, LLC on July 30, 2024.
- Exchange Amount: $100,000 principal partitioned from the original note.
- Equity Issued: 480,769 ordinary shares (par value $0.20) issued in exchange for the $100,000 debt.
- Remaining Debt: The outstanding balance of the original note was reduced by the exchange amount.
Material Changes and Unusual Items
The filing does not provide comparative financial statements (revenue, profit, or cash flow) for the period. The material changes are strictly transactional:
- Strategic Expansion: Entry into forestry management and product sales via the acquisition of a 45% stake in a subsidiary of MALONG LIMITED.
- Capital Structure Adjustment: Reduction of debt liability by $100,000 through the issuance of equity, executed under Section 3(a)(9) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future financial performance. Risks and contingencies are limited to the closing conditions of the Equity Transfer Agreement, which include:
- Completion of the first installment payment to trigger the closing date.
- Amendment of the Target's articles of association.
- Formal transfer of equity within one month of the first payment.
- Establishment of a two-member board of directors with equal representation.
Investor Verification Checklist
- Verify the completion of the first $35 million cash payment and the transfer of $35 million in accounts receivable by March 31, 2025.
- Confirm the regulatory approval and amendment of the Target's articles of association in Hong Kong.
- Review the full text of the Equity Transfer Agreement (Exhibit 10.1) for specific closing conditions and representations.
- Assess the impact of the $29 million deferred payment obligation on future liquidity.
- Confirm the registration status of the 480,769 shares issued to Atlas Sciences, LLC.